Are we mapping a path to CRISPR babies?
By Katie Hasson and Marcy Darnovsky,
The Hill
| 09. 13. 2020
In November 2018, at a gene-editing “summit” hosted by scientific societies from the U.S., the U.K., and Hong Kong, a Chinese researcher announced that he had created the world’s first genetically modified babies. He Jiankui fully expected to be celebrated for a scientific breakthrough; he mentioned the Nobel Prize. Instead, he was almost universally condemned.
Key figures associated with the U.S. National Academies and U.K. Royal Society joined in the criticism but did not reject heritable genome editing. Instead, they objected to the Chinese researcher’s timing. It was too soon, they said. It hadn’t been done as they thought it should have been. But according to the researcher now being called a “rogue,” it was the National Academies’ 2017 report that had given him the green light for his experiments.
In the aftermath of this headline-grabbing debacle, the scientific societies decided on a do-over. They declared it time to “define a rigorous, responsible translational pathway” toward clinical use of heritable genome editing. They set up a carefully selected international commission with the mandate to map the scientific details... see more
Related Articles
By Fiona Harvey, The Guardian | 01.06.2021
By Jeffrey Mervis, Science | 01.06.2021
Low-income commuters who rely on public transit face many challenges—multiple transfers, long waits, and off-hour travel—that aren’t measured in the usual ridership surveys. Vanessa Frias-Martinez, a computer scientist at the University of Maryland, College Park, wants to ease their commute...
By Sharon Begley, STAT | 01.06.2021
Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute therefore had no plans to present such findings, which he’d peeked at...
By Gwen D’Arcangelis, Guest Contributor
| 01.07.2021
Photo by Adrian Lange on Unsplash
Living under the COVID-19 pandemic has justifiably created fear and uncertainty about germs and their evolving contagiousness and lethality. Against the backdrop of the natural evolution of the coronavirus and emerging new strains, many ruminate over further alarming scenarios—from questions about the coronavirus’s possible lab origins, to worry over the possibility of biohackers engineering new pandemic germs. New gene editing technologies like CRISPR make these scenarios all the more frightening, as they...